Ledger.Open graph →
SEC Form D · filed November 18, 2022

VYNE Therapeutics Inc

Offering
$300K
Sold
$300K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven Basta · BRIDGEWATER, NJDirectorAnthony Bruno · Pompano Beach, FLDirectorPatrick Lepore · BRIDGEWATER, NJDirectorIain Stuart · BRIDGEWATER, NJExecElisabeth Sandoval · BRIDGEWATER, NJDirectorDavid Domzalski · BRIDGEWATER, NJExec · DirectorTyler Zeronda · BRIDGEWATER, NJExecMutya Harsch · BRIDGEWATER, NJExecSharon Barbari · BRIDGEWATER, NJDirectorSteven Basta · Palo Alto, CADirectorAnthony Bruno · Austin, TXDirectorPatrick Lepore · BRIDGEWATER, NJDirectorIain Stuart · BRIDGEWATER, NJExecElisabeth Sandoval · BRIDGEWATER, NJDirectorDavid Domzalski · BRIDGEWATER, NJExec · DirectorTyler Zeronda · BRIDGEWATER, NJExecMutya Harsch · BRIDGEWATER, NJExecSharon Barbari · BRIDGEWATER, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗